Literature DB >> 27273736

Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.

Philipp Mahlknecht1,2, Arno Gasperi3, Peter Willeit1,4,5, Stefan Kiechl1, Heike Stockner1, Johann Willeit1, Gregorio Rungger3, Martin Sawires1, Michael Nocker1, Verena Rastner1, Katherina J Mair1, Anna Hotter1, Werner Poewe6, Klaus Seppi7.   

Abstract

BACKGROUND: Recently, the International Parkinson and Movement Disorder Society has defined research criteria for prodromal Parkinson's disease (PD), but to date their predictive value has not yet been tested in population-based cohorts.
METHODS: We retrospectively applied these criteria to the longitudinal Bruneck Study cohort aged 55-94 years using recorded data on all included risk and prodromal markers that are quick and easily assessable.
RESULTS: After excluding participants with idiopathic PD or secondary parkinsonism, prevalence of probable prodromal PD in the remaining 539 participants was 2.2% (95% confidence interval, 1.2%-3.9%). Of 488 participants followed up over 5 years, 11 developed incident PD. Sensitivity of "probable prodromal PD" status for incident PD was 54.6% (95% confidence interval, 28.0%-78.8%), specificity was 99.2% (97.8%-99.8%), positive predictive value was 60.0% (31.2%-83.3%), and negative predictive value was 99.0% (97.5%-99.6%).
CONCLUSIONS: Our findings suggest that the new research criteria for prodromal PD are a promising tool to identify cases of incident PD over 5 years, arguing for their usefulness in defining target populations for disease-prevention trials.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  mild parkinsonian signs (MPS); olfactory dysfunction; probability; probable prodromal Parkinson's disease; transcranial sonography (TCS)

Mesh:

Year:  2016        PMID: 27273736     DOI: 10.1002/mds.26674

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

Review 1.  [Diagnostics of clinical and prodromal idiopathic Parkinson's disease : New criteria].

Authors:  H Zach; U Walter; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 2.  Biomarkers of Parkinson's disease: 20 years later.

Authors:  Rezzak Yilmaz; Franziska Hopfner; Thilo van Eimeren; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2019-04-04       Impact factor: 3.575

Review 3.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

Review 4.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

Review 5.  Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?

Authors:  Weidong Le; Jie Dong; Song Li; Amos D Korczyn
Journal:  Neurosci Bull       Date:  2017-09-02       Impact factor: 5.203

6.  Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.

Authors:  Anat Mirelman; Rachel Saunders-Pullman; Roy N Alcalay; Shiran Shustak; Avner Thaler; Tanya Gurevich; Deborah Raymond; Helen Mejia-Santana; Martha Orbe Reilly; Laurie Ozelius; Lorraine Clark; Mali Gana-Weisz; Anat Bar-Shira; Avi Orr-Utreger; Susan B Bressman; Karen Marder; Nir Giladi
Journal:  Mov Disord       Date:  2018-03-30       Impact factor: 10.338

7.  Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.

Authors:  Thomas R Barber; Michael Lawton; Michal Rolinski; Samuel Evetts; Fahd Baig; Claudio Ruffmann; Aimie Gornall; Johannes C Klein; Christine Lo; Gary Dennis; Oliver Bandmann; Timothy Quinnell; Zenobia Zaiwalla; Yoav Ben-Shlomo; Michele T M Hu
Journal:  Sleep       Date:  2017-08-01       Impact factor: 5.849

8.  Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Authors:  Kathrin Doppler; Hanna-Maria Jentschke; Lena Schulmeyer; David Vadasz; Annette Janzen; Markus Luster; Helmut Höffken; Geert Mayer; Joachim Brumberg; Jan Booij; Thomas Musacchio; Stephan Klebe; Elisabeth Sittig-Wiegand; Jens Volkmann; Claudia Sommer; Wolfgang H Oertel
Journal:  Acta Neuropathol       Date:  2017-02-08       Impact factor: 17.088

9.  Probing the Pre-diagnostic Phase of Parkinson's Disease in Population-Based Studies.

Authors:  Lisanne J Dommershuijsen; Agnita J W Boon; M Kamran Ikram
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

10.  Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.

Authors:  Avner Thaler; Shani Shenhar-Tsarfaty; Yanay Shaked; Tanya Gurevich; Nurit Omer; Anat Bar-Shira; Mali Gana-Weisz; Orly Goldstein; Meir Kestenbaum; Jesse M Cedarbaum; Avi Orr-Urtreger; Nir Giladi; Anat Mirelman
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.